Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Rating of “Moderate Buy” by Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given a consensus recommendation of “Moderate Buy” by the ten analysts that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $86.67.

ACHC has been the topic of several research reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. Barclays lowered their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, September 30th. KeyCorp initiated coverage on Acadia Healthcare in a report on Friday. They set a “sector weight” rating for the company. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $54.82 on Friday. The company has a market cap of $5.09 billion, a P/E ratio of -391.57, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29. The company’s fifty day moving average is $72.20 and its two-hundred day moving average is $70.25. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 12-month low of $53.22 and a 12-month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The firm had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.92 EPS. Equities analysts expect that Acadia Healthcare will post 3.51 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of the company. Blue Trust Inc. grew its stake in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after buying an additional 248 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Mather Group LLC. bought a new position in shares of Acadia Healthcare in the first quarter worth about $48,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $59,000. Finally, nVerses Capital LLC acquired a new stake in Acadia Healthcare in the 2nd quarter valued at approximately $95,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.